MedinCell announces the great success of its capital increase and raises 15.6 M€
17 June 2020

MedinCell announces the great success of its capital increase and raises 15.6 M€

MedinCell (FR0004065605 - MEDCL), a clinical stage pharmaceutical company that develops a portfolio of long-acting injectable products in various therapeutic areas (the...

By continuing your browsing on this site, you accept the use of cookies to carry out statistics of anonymous visits. Read more

Authorize Refuse